Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Insmed (INSM) EPS (Basic) (2016 - 2026)

Insmed's EPS (Basic) history spans 17 years, with the latest figure at -$0.76 for Q1 2026.

  • Quarterly EPS (Basic) rose 46.48% to -$0.76 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.74 through Mar 2026, up 3.2% year-over-year, with the annual reading at -$6.42 for FY2025, 15.26% down from the prior year.
  • EPS (Basic) came in at -$0.76 for Q1 2026, up from -$1.53 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.76 in Q1 2026 to a low of -$1.94 in Q2 2024.
  • The 5-year median for EPS (Basic) is -$1.27 (2024), against an average of -$1.29.
  • Year-over-year, EPS (Basic) plummeted 122.5% in 2023 and then soared 46.48% in 2026.
  • Insmed's EPS (Basic) stood at -$1.23 in 2022, then dropped by 4.07% to -$1.28 in 2023, then dropped by 1.56% to -$1.3 in 2024, then fell by 17.69% to -$1.53 in 2025, then surged by 50.33% to -$0.76 in 2026.
  • Per Business Quant, the three most recent readings for INSM's EPS (Basic) are -$0.76 (Q1 2026), -$1.53 (Q4 2025), and -$1.75 (Q3 2025).